Icon

ELAVIL (nda012703)- (10MG,25MG,50MG,75MG,100MG,150MG)

AMITRIPTYLINE HYDROCHLORIDE ASTRAZENECA
10MG,25MG,50MG,75MG,100MG,150MG
No No
Expired Expired
None None
None No
ELAVIL is indicated for the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than are other depressive states.
19 0 11
Total Other Developers None
Drugs with Suitability No
10MG ** ** - - 9
25MG ** ** - - 9
50MG ** ** - - 8
75MG ** ** - - 9
100MG ** ** - - 8
150MG ** ** - - 8
NDA Sales Available Total Generic Sales Available
No 9
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** ********** ******** ***** ** *** */*/* ******** ************ *********** **** ******** ****., *********, ***** ******** (**) *****, ****** ****** (***) ***
****** ****** ****** ******* ******* *********** **** **. *-*/* *** *-*, *** ********** **** ***** *****, ******* *****, **** ******, *********** ******, ***** (***) ***
****** *** ***** **** *** ******** ********, *** *********** **** ******** ******, ************, ************ (**) *****, ****** ****** (***) ***
****** *** ***** **** *** ********* ********** **** ********** ****** **************** *********** ***** ***** *. **., ************, - *****, ******* (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. * ** **, *******, **** ******* ******, *******-***** *******, **. *-*, ****** ******, *********, ******* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** ******* ****** *****, *.*. *****, ******-********, *****, ******** ******* ******, ***** (***) ***
****** ****** ***** *** ******** ******* ************** **., ***. *********** **.***, ******** ***. **** **., ***** **., ******** ******, ********, ******** ******, ***** (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***
****** ************ ******* *************** ******* ******* *********** **** **. *, ************* ******* ****, *****-**, *********, ****, *********** ******, ***** (***) ***
****** ******* ******* ******** ******* *********** **** ** *-**/* & ***/*, ****, ********** ********* ****,, *****, *********** *** ***, ***** (***) ***
****** ****** ******* *************** ******* ******* *********** ****** **. ***/* & ***/**, ******* *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ******* ******* ************ **, ***. *********** **** ****** *****, **** **********, ******* (**) *****, ****** ****** (***) ***
****** ******* ******* ************ ******* *********** **** **. ** ** **, ******* ********** ******, *******, ******, *** ******, ***** (***) ***
****** ******* ******* ************ ******* *********** *-**, ** & *-**, ********** ****, ****** ****, *********, ***** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.